05 Nov 2024 11:00 CET

Issuer

Nordhealth AS

Nordhealth will report and present its Q3 2024 results on Tuesday the 12[th] of
November 2024.

The results will be presented in a live presentation and subsequent Q&A session
with CEO Charles MacBain and CFO Mari Laine on the 12[th] of November at 13:00
CET.

Please use the following link to attend: https://us02web.zoom.us/j/88457477200

The presentation will be recorded and made available on www.nordhealth.com. The
presentation material for Q3/2024 will be available on 12 November 2024 at 07:30
am CET on www.newsweb.no and on Nordhealth's IR
website https://nordhealth.com/investor/news-and-documents/

For further information, please contact:

Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200

Mari Laine, CFO mari.laine@nordhealth.com +358 46 8765 233

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 60,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with 400 employees working
either remotely or from offices (collaboration hubs). Visit the company's
website at nordhealth.com (http://www.nordhealth.com).


Source

Nordhealth AS

Provider

Oslo Børs Newspoint

Company Name

NORDHEALTH AS A-AKSJER

ISIN

NO0011002651

Symbol

NORDH

Market

Euronext Growth